Coleus (Makandi) for Weight Management

Research suggests that Coleus forskohlii and its active compound forskolin have demonstrated consistent effects on reducing body weight, fat mass, food intake, and adipocyte size in multiple animal studies, with proposed mechanisms including activation of the cAMP-PKA signaling pathway, promotion of fatty acid beta-oxidation, and thermogenesis. Human evidence, however, is considerably weaker: the available clinical data consists of limited randomized controlled trials, including one 12-week study that found no statistically significant changes in body composition and only a non-significant trend toward less weight gain, and a 2023 multi-ingredient supplement trial that showed positive results but cannot isolate forskolin's individual contribution. Multiple reviews across the past decade consistently characterize the human evidence as insufficient to support clear recommendations for weight loss use, and at least one animal study raised dose-dependent hepatotoxicity concerns, adding a note of caution to its safety profile. Overall, while preclinical findings are mechanistically plausible and moderately supportive, the translation to meaningful, sustained weight loss in humans remains unestablished, and interested readers should weigh the limited and mixed clinical record accordingly.